GNH USA

Europe — EMA

Meronem

GNH USA supplies Meronem (Meropenem), a carbapenem antibiotic for complicated intra‑abdominal infections, hospital‑acquired pneumonia and severe sepsis.

Meropenem Anhydrous

Request sourcing

1
Pack/s

What is Meropenem Anhydrous?

Meropenem, the active ingredient in Meronem, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia, ventilator‑associated pneumonia, and severe sepsis or septic shock in hospitalized patients.

GNH USA supplies Meronem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Meropenem Anhydrous used for?

Meronem is a carbapenem antibiotic used to treat serious bacterial infections in hospitalized patients.

- Complicated intra‑abdominal infections: achieves clinical cure and microbiological eradication. - Complicated urinary tract infections: resolves infection and prevents progression. - Hospital‑acquired pneumonia: improves survival and clears pulmonary infection. - Ventilator‑associated pneumonia: reduces bacterial load and supports respiratory recovery. - Severe sepsis and septic shock: contributes to rapid bacterial clearance and hemodynamic stabilization.

What are the side effects of Meropenem Anhydrous?

Adverse reactions may occur with any intravenous antibiotic and should be monitored during therapy.

Common Side Effects: - Nausea - Diarrhea - Vomiting - Infusion‑site phlebitis - Headache - Elevated liver enzymes

Serious or Rare Side Effects: - Seizures, especially in patients with CNS disorders - Anaphylaxis or severe allergic reactions - Clostridioides difficile‑associated colitis - Acute renal impairment - Neutropenia or thrombocytopenia - Severe skin reactions such as Stevens‑Johnson syndrome

What precautions apply to Meropenem Anhydrous?

Use of Meronem requires careful clinical assessment and monitoring.

- Renal function assessment: adjust dose in renal impairment. - Monitor for seizures: avoid in patients with a history of epilepsy. - Hypersensitivity: discontinue if allergic reaction occurs. - Caution in CNS disorders: increased risk of neurotoxicity. - Hepatic monitoring: observe liver enzyme elevations. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Meropenem Anhydrous interact with?

Meronem can interact with several medicines, requiring vigilance.

Major Interactions (Avoid): - Valproic acid: may reduce valproate levels, risking seizure breakthrough. - Probenecid: can increase meropenem plasma concentrations, heightening toxicity. - Other carbapenems: concurrent use may lead to cumulative toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of meropenem. - Anticoagulants (e.g., warfarin): monitor INR for potential changes. - NSAIDs: combined renal stress may increase risk of kidney injury.

Frequently asked questions

What infections is Meronem used to treat?+
Meronem (meropenem) is indicated for severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia, ventilator‑associated pneumonia, and severe sepsis or septic shock in hospitalized patients.
How does meropenem work against bacteria?+
Meropenem binds to penicillin‑binding proteins on bacterial cell walls, blocking the final steps of peptidoglycan cross‑linking. This weakens the cell wall, causing osmotic rupture and bacterial death, providing broad‑spectrum activity against many Gram‑negative, Gram‑positive and anaerobic organisms.
What is the usual dose of Meronem?+
The dosage of Meronem is individualized by the prescribing clinician based on infection severity, patient weight, renal function and local guidelines. Only a qualified healthcare professional should determine the appropriate regimen.
Is Meronem safe during pregnancy or breastfeeding?+
Safety data for meropenem in pregnancy and lactation are limited. The drug should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the treating physician.
How do I order Meronem from GNH USA?+
To request Meronem, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Meronem compare with other carbapenems?+
Meronem (meropenem) shares the carbapenem class’s broad‑spectrum activity but offers enhanced stability against many β‑lactamases, providing reliable coverage for resistant Gram‑negative pathogens. Compared with imipenem‑cilastatin, meropenem does not require co‑administration of a renal dehydropeptidase inhibitor, simplifying dosing.
What are the storage and handling requirements for Meronem?+
Meronem should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Once reconstituted, the solution should be used within the time frame specified in the product labeling and kept under the same temperature conditions.
How is Meronem administered to patients?+
Meronem is supplied as an injectable solution for intravenous infusion. It is administered by a healthcare professional through a peripheral or central line, typically over a 15‑30 minute infusion period, following the dose prescribed by the clinician.
What are the most serious risks associated with Meronem?+
Serious adverse events include seizures, especially in patients with pre‑existing CNS disorders, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and acute renal impairment. Prompt recognition and discontinuation are essential if these occur.
Who should not receive Meronem?+
Patients with a known hypersensitivity to meropenem, other carbapenems, or any component of the formulation should avoid Meronem. Caution is also advised for individuals with a history of seizures, severe renal dysfunction, or uncontrolled epilepsy, where alternative therapy may be preferred.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Meropenem Anhydrous
Route
Intravenous Use
Manufacturer
Pfizer Holding France
Origin
EU

Related products